Näytä suppeat kuvailutiedot

dc.contributor.authorde Freitas Almeida, Gabriel Magno
dc.contributor.authorSundberg, Lotta-Riina
dc.date.accessioned2020-05-04T10:15:42Z
dc.date.available2020-05-04T10:15:42Z
dc.date.issued2020
dc.identifier.citationde Freitas Almeida, G. M., & Sundberg, L.-R. (2020). The forgotten tale of Brazilian phage therapy. <i>The Lancet Infectious Diseases</i>, <i>20</i>(5), e90-e101. <a href="https://doi.org/10.1016/S1473-3099(20)30060-8" target="_blank">https://doi.org/10.1016/S1473-3099(20)30060-8</a>
dc.identifier.otherCONVID_35102550
dc.identifier.urihttps://jyx.jyu.fi/handle/123456789/68812
dc.description.abstractThe use of bacteriophages to treat bacterial infections (known as phage therapy) is considered a possible solution to the antimicrobial resistance crisis. However, phage therapy is not a new concept. The discovery of phages in the early 20th century was closely tied to clinical practice, and phage therapy quickly spread around the world. The use of phage therapy in South America in the previous century is still shrouded in mystery and has been mentioned only briefly in recent scientific literature. Research on Brazilian reference collections of medical texts showed that Brazil was an important, but so far little-known, player of phage therapy, uncovering interesting priority claims and missing pieces of phage therapy history. Of note, there is the widespread use of phages against bacillary dysentery and staphylococcal infections, with José da Costa Cruz from the Oswaldo Cruz Institute (Rio de Janeiro, Brazil) as Brazil's leading expert and pioneer. This Historical Review about historical phage use in Brazil fills the gaps in our knowledge about the so-called golden years of phage therapy, providing information about successful experiences that can be useful against dangerous pathogens in our time.en
dc.format.mimetypeapplication/pdf
dc.languageeng
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofseriesThe Lancet Infectious Diseases
dc.rightsCC BY-NC-ND 4.0
dc.subject.otherBrasilia
dc.subject.otherbacteriophages
dc.subject.otherbacterial infections
dc.subject.otherphage therapy
dc.subject.otherBrazil
dc.titleThe forgotten tale of Brazilian phage therapy
dc.typearticle
dc.identifier.urnURN:NBN:fi:jyu-202005043032
dc.contributor.laitosBio- ja ympäristötieteiden laitosfi
dc.contributor.laitosDepartment of Biological and Environmental Scienceen
dc.contributor.oppiaineNanoscience Centerfi
dc.contributor.oppiaineSolu- ja molekyylibiologiafi
dc.contributor.oppiaineNanoscience Centeren
dc.contributor.oppiaineCell and Molecular Biologyen
dc.type.urihttp://purl.org/eprint/type/JournalArticle
dc.type.coarhttp://purl.org/coar/resource_type/c_dcae04bc
dc.description.reviewstatuspeerReviewed
dc.format.pagerangee90-e101
dc.relation.issn1473-3099
dc.relation.numberinseries5
dc.relation.volume20
dc.type.versionacceptedVersion
dc.rights.copyright© 2020 Elsevier Ltd. All rights reserved.
dc.rights.accesslevelopenAccessfi
dc.relation.grantnumber314939
dc.subject.ysofagiterapia
dc.subject.ysobakteeritaudit
dc.subject.ysobakteriofagit
dc.subject.ysotutkimushistoria
dc.subject.ysooppihistoria
dc.format.contentfulltext
jyx.subject.urihttp://www.yso.fi/onto/yso/p29496
jyx.subject.urihttp://www.yso.fi/onto/yso/p19293
jyx.subject.urihttp://www.yso.fi/onto/yso/p25303
jyx.subject.urihttp://www.yso.fi/onto/yso/p21028
jyx.subject.urihttp://www.yso.fi/onto/yso/p16329
dc.rights.urlhttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.relation.doi10.1016/S1473-3099(20)30060-8
dc.relation.funderResearch Council of Finlanden
dc.relation.funderSuomen Akatemiafi
jyx.fundingprogramAcademy Project, AoFen
jyx.fundingprogramAkatemiahanke, SAfi
jyx.fundinginformationThis study was funded by the Academy of Finland (grant #314939) and by the Jane and Aatos Erkko Foundation. This work resulted from the BONUS FLAVOPHAGE project supported by BONUS (Art 185), funded jointly by the EU and Academy of Finland
dc.type.okmA2


Aineistoon kuuluvat tiedostot

Thumbnail

Aineisto kuuluu seuraaviin kokoelmiin

Näytä suppeat kuvailutiedot

CC BY-NC-ND 4.0
Ellei muuten mainita, aineiston lisenssi on CC BY-NC-ND 4.0